Lipoprotein (A) Levels in Renal Transplant Recipients Receiving Cyclosporin Monotherapy
Article Sidebar
Main Article Content
Abstract
Elevated serum levels of lipoprotein (a) LP(a) are a known risk factor for coronary heart disease in the general population. We measured the serum concentration of Lp(a) in 63 renal transplant recipients (41 male, 22 female) on cyclosporin monotherapy, and in 137 healthy controls. Serum Lp(a) levels were significantly elevated in the transplant patients with a median of 30.1 (range < 0.8 - 140.3) mg/dl compared to 8.19 (range < 0.8 - 87.4)mg/dl in controls. This raised serum level of Lp(a) may contribute to the excessive cardiovascular morbidity that occurs following renal transplanation.
Article Details
How to Cite
1.
Anwar N, Brown H, Short C. Lipoprotein (A) Levels in Renal Transplant Recipients Receiving Cyclosporin Monotherapy. J Postgrad Med Inst [Internet]. 2011 Sep. 22 [cited 2024 Nov. 22];16(1). Available from: https://jpmi.org.pk/index.php/jpmi/article/view/753
Issue
Section
Original Article
Work published in JPMI is licensed under a
Creative Commons Attribution-NonCommercial 2.0 Generic License.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.